Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
Sean J. Pittock(Mayo Clinic), Sebastian A. Lopez Chiriboga(Mayo Clinic), Katie Dunlay(Mayo Clinic), Melanie Ramberger(University of Oxford), Αναστασία Ζεκερίδου(Mayo Clinic), Patrick Waters(University of Oxford), Jessica Sagen(Mayo Clinic), Sarosh R. Irani(John Radcliffe Hospital), Michelle F. Devine(Mayo Clinic), Andrew McKeon(Université Claude Bernard Lyon 1), Jeffrey W. Britton(Mayo Clinic), Jane H. Cerhan(Mayo Clinic), Avi Gadoth
Cited by 159
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k
The spectrum of neuromyelitis optica
|The Lancet Neurology|2007|2.2k